The mammalian transcriptional factors, Cdx1 and Cdx2 (Cdx is caudal-type homeobox) are paralogues and critical for the cellular differentiation of intestinal or colorectal epithelia. It has been reported previously that in Cdx1 transgenic or knockout mice, endogenous Cdx2 levels are inversely correlated with Cdx1 levels. Recently, we found that exogenous Cdx1 expression can suppress Cdx2 in a human colorectal tumour cell line, SW480, although the underlying molecular mechanisms were unclear. In the present study, we show that several microRNAs induced by exogenous Cdx1 expression directly bind to the CDX2 mRNA 3 UTR (untranslated region) to destabilize these transcripts, finally leading to their degradation. Using microarray analysis, we found that several miRNAs that were computationally predicted to target CDX2 mRNAs are up-regulated by exogenous Cdx1 expression in SW480 cells. Among these molecules, we identified miR-9, miR-16 and miR-22 as having the potential to suppress Cdx2 through the binding of the 3 UTR to its transcript. Importantly, simultaneous mutations of both the miR-9-and miR-16-binding sites in the CDX2 3 UTR were shown to be sufficient to block Cdx2 suppression. The results of the present study suggest a unique feature of miRNAs in which they contribute to homoeostasis by limiting the levels of transcription factors belonging to the same gene family.
INTRODUCTION
Cdx (caudal-type homeobox) genes encode HOX domaincontaining transcription factors that are conserved among vertebrates. In mouse and humans, these genes are expressed during development in a tissue-specific manner and contribute to the formation of the anterior-posterior axis. In adults, two paralogues, Cdx1 and Cdx2, are expressed in the intestinal epithelium, and aberrant expression is often associated with metaplasias or tumour formation [1, 2] . These factors have in fact been shown to be expressed in intestinal metaplasias [3] , which are lesions that can progress to gastric adenocarcinoma. These two paralogous proteins are expected to play, at least partially, similar roles in the regulation of target gene expression by binding to identical recognition sequences [4, 5] . However, it has also been shown that there are several regulatory interactions between Cdx1 and Cdx2 [6, 7] , suggesting that these two homologous transcription factors are not always functionally redundant.
Previous observations in Cdx1 transgenic mice and Cdx1
mice have indicated that altered Cdx1 levels cause an inverse and dose-dependent modification of endogenous Cdx2 protein expression in the distal colon and jejunum [8] . It has also been reported that the expression of endogenous Cdx2 protein and mRNA is drastically reduced by ectopic Cdx1 expression in the small intestinal villi and colon surface epithelium of mice [9] . These results suggest that Cdx1 fine-tunes the expression of the Cdx2 gene. Importantly, we have shown that ectopic Cdx1 expression in the colon cancer cell line SW480 significantly reduces endogenous Cdx2 protein [10] . miRNAs (microRNAs) are a group of 19-25 bp small RNAs that function as gene repressors of a vast range of genes via their direct binding to the 3 UTR (untranslated region) of the corresponding mRNAs in a sequence-specific manner [11, 12] . Given that several layers of regulation are likely to underlie the suppression of Cdx2 by Cdx1, we speculated that miRNAs would be involved in some of these pathways as the 3 UTR sequences of the CDX1 and CDX2 transcripts are not homologous. miRNA binding is largely dependent upon a 7 bp 'seed' sequence which corresponds to the 2-8 nt from the 5 -end of each of these molecules [13] . Since miRNAs depend on relatively weak binding specificity, they can potentially regulate hundreds of genes simultaneously and, at the same time, a specific mRNA can be targeted by multiple miRNAs [13] . In the present study, we show using colon tumour cell lines that Cdx1 induces the expression of several miRNAs, some of which repress Cdx2 expression.
EXPERIMENTAL Cell culture, transduction of virus vectors and transfection of plasmids
Established human cell lines SW480 (colorectal tumour), T84 (colorectal tumour) and PLAT [HEK (human embryonic kidney)-293 cells carrying pGag-pol-IRES-bs r ] were grown in DMEM (Dulbecco's modified Eagle's medium; Gibco) with 10 % FBS (fetal bovine serum; Wako). SW480 or T84 cells were transduced with the VSV-G (vesicular stomatitis virus glycoprotein) pseudotype retrovirus vector pMXs-IP (empty vector) or pMXs-Cdx1-IP (Cdx1 vector) after concentration by centrifugation. For selection, the cells were then cultivated for 4-6 days in the presence of 4.0 μg/ml puromycin. SW480 cells Abbreviations used: CDX/Cdx, caudal-type homeobox; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; miRNA, microRNA; RT, reverse transcription; UTR, untranslated region; VSV-G, vesicular stomatitis virus glycoprotein. 1 To whom correspondence should be addressed (email iba@ims.u-tokyo.ac.jp).
were transfected with plasmids using Lipofectamine TM 2000 (Invitrogen) following the manufacturer's protocols and then cultivated for an additional 48 h.
Retroviral vector
PLAT cells (4×10 6 ) were co-transfected with 2.7 μg of pCAG-VSV-G and 8 μg of either pMXs-IP or pMXs-Cdx1-IP [10] using Lipofectamine TM 2000. Supernatants were collected at 24 and 48 h after transfection, mixed and kept as VSV-G pseudotype retrovirus stocks.
Plasmid construction
Oligonucleotides listed in Supplementary Table S1 (at http:// www.BiochemJ.org/bj/447/bj4470449add.htm) were used as primers for the PCR cloning of the 3 UTR of CDX2 mRNA (NM_ 001265.4) from the HCT116 genome. The amplified product was subcloned into the pGEM-T Easy vector (Promega) to generate pGEM-T Easy-Cdx2_3 UTR. For the generation of luciferase reporter vectors with mutations at putative miRNA-binding sites, site-directed mutagenesis was performed using Pyrobest (TaKaRa Bio) and the oligonucleotides listed in Supplementary Table S1 . Both wild-type and mutated vectors were then digested by NotI in the presence of alkaline phosphatase (TaKaRa Bio) and the resultant 3 UTR fragments were inserted into the NotI site of psiCHECK-2 (Promega) to generate the luciferase assay reporter vector psiCHECK-2-Cdx2_3 UTR and mutated reporter vectors as shown in Figure 2 , and Supplementary Figures S1 and S2 (at http://www.BiochemJ.org/bj/447/bj4470449add.htm). The oligonucleotides used as primers for mutagenesis were designed not to create unintended sequences which have Watson-Crick-type complementarity to the seed sequences (2-8 nt from the 5 -end) of any human microRNAs listed in miRBase Release 14 (http://www. mirbase.org/) [14] .
The oligonucleotides listed in Supplementary Table S1 were also used as PCR primer pairs to synthesize DNA with pre-miRNA sequences acquired from miRBase Release 14. After digestion with BbsI and EcoRI, the amplicons were inserted into the BbsI/EcoRI site of pmU6 [15] to generate pmU6-miR9-3, pmU6-miR22-2, pmU6-miR107 and pmU6-miR181b-2 respectively. For miR16-1, the amplified DNA insert was subcloned into the pCR2.1 vector and digested with BbsI and EcoRI. The resultant fragment was then inserted into the BbsI/EcoRI site of pmU6 [15] to generate pmU6-miR16-1.
Protein and RNA preparation
Total proteins were extracted from cells using SDS buffer [100 mM Tris/HCl (pH 6.8), 12 % 2-mercaptoethanol, 20 % glycerol and 2 % SDS] and heating at 95
• C for 10 min. Total RNAs were extracted using the mirVana miRNA Isolation kit (Applied Biosystems) in accordance with the manufacturer's instructions.
Immunoblotting analysis
Protein samples were separated by SDS/PAGE (12 mA for 60 min, followed by 24 mA for 90 min) and transferred on to an Immobilon-P (Millipore) filter under 20 % methanol/80 % TrisGlycine buffer [25 mM Tris and 192 mM glycine (pH 8.5)] for 1 h at 120 V. For blocking, the membrane was soaked with 5 % (w/v) non-fat dried skimmed milk (Wako), 95 % PBS (tubulin and Cdx1) or TBST (Tris-buffered saline pH 7.4 with 0.05% Tween 20) (Cdx2), shaken for 60 min and then incubated with primary antibody diluted in 1 % (w/v) non-fat dried skimmed milk in PBS (tubulin and Cdx1) or TBST (Cdx2) for 16 h at 4
• C. After washing with PBS (tubulin and Cdx1) or TBST (Cdx2), the membrane was reacted with secondary antibody [donkey anti-rabbit HRP (horseradish peroxidase) conjugate (Millipore)] diluted to 1:3000 by 1 % (w/v) non-fat dried skimmed milk in PBS (tubulin and Cdx1) or TBST (Cdx2), for 1 h at room temperature (22
• C). After washing with PBS (tubulin and Cdx1) or TBST (Cdx2), signals were detected using an ECL (enhanced chemiluminescence) kit (GE Healthcare) or ImmunoStar TM kit (Wako). Detection and quantification was performed using a LAS-4000 UVmini imager (Fuji Film). The primary antibodies used and their dilution ratios were as follows: anti-tubulin (used at 1:10000, rabbit IgG; Abcam) and anti-Cdx2 (used at 1:100, rabbit IgG; Cell Signaling Technology). Rabbit polyclonal antibodies against human Cdx1 were raised against a synthetic peptide (CLATSSP-MPVKEEFLP) and the dilution ratio for immunoblotting was 1:200.
Quantitative RT (reverse transcription)-PCR
The oligonucleotides listed in Supplementary Table S1 were used as primer pairs to assay CDX2 and GAPDH (glyceraldehyde-3-phosphate dehydrogenase) mRNA by quantitative RT-PCR. The Prime Script RT-PCR kit (TaKaRa Bio) was used for RT, and SYBR Green PCR Master Mix (Applied Biosystems) and the ABI 7300 real-time PCR system (Applied Biosystems) were used for real-time PCR in accordance with the manufacturer's instructions. For miRNAs, the TaqMan miRNA RT Kit (Applied Biosystems) was used for RT and TaqMan Universal PCR Master Mix (Applied Biosystems) and the ABI 7300 real-time PCR system (Applied Biosystems) were used for real-time PCR and detection respectively, in accordance with the manufacturer's instructions. Student's t test analysis was performed for each analysis.
Dual luciferase assay

SW480 cells (1×10
5 cells per well in a 24-well plate) or transduced SW480 cells (1×10 4 cells per well in a 24-well plate) were transfected with 50 ng of luciferase assay reporter vectors and analysed using the Dual-Luciferase Reporter Assay system (Promega) and Glo-max 96 Microplate Luminometer (Promega) to detect both firefly luciferase activity and Renilla luciferase activity. Firefly luciferase activity was used as an internal control to normalize the Renilla luciferase activity levels. Student's t test was performed for each analysis.
Analysis of miRNAs by microarray
miRNA microarray Rel.12.0 (Agilent Technologies), a SpikeIn kit (Agilent Technologies) and an Agilent DNA Scanner C type (Agilent Technologies) were used to analyse human miRNA expression profiles. For calibration and quantification, Feature Extraction software (Agilent Technologies) was used and probes with a detected raw signal <1.0 were excluded as background noise. As a result, 198 out of 851 human miRNAs listed in miRBase Reference 12 were detected either using the pMXs-IP data set or pMXs-Cdx1 data set. Values acquired from each probe were processed on Microsoft Excel and the signals of undetected probes were set to 1.0 as a logarithm scale was used for this analysis. 
RESULTS
Exogenously expressed Cdx1 suppresses both Cdx2 protein and mRNA expression in the SW480 and T84 colorectal tumour cell lines
We selected two colorectal cancer cell lines, SW480 and T84, to analyse the molecular mechanisms of Cdx2 suppression by Cdx1. This is because both SW480 and T84 express CDX2 mRNA at high levels, and also because SW480 practically does not express CDX1 and T84 expresses CDX1 only marginally [10, 16] . Consistent with our previous observation [10] , SW480 cells transduced with a Cdx1 retrovirus vector at several doses showed a significant loss of Cdx2 protein when compared with those transduced with the empty vector ( Figure 1A) . Quantitative RT-PCR analysis further revealed that CDX2 mRNA was also suppressed in these cells ( Figure 1B) .
Although it was previously reported that, in mice intestine or colon epithelium, exogenous expression of Cdx1 decreases Cdx2 only when Cdx1 expression surpasses a certain threshold [8, 9] , the results from our in vitro carcinoma cell line system suggest that Cdx1 transduction was so efficient that even the smallest dose was sufficient to maximally suppress Cdx2 (Figure 1) .
A similar suppression of Cdx2 protein or CDX2 mRNA by exogenous expression of Cdx1 was observed in the experiment using the T84 cell line (Figure 1 ).
Various miRNAs are induced by exogenous Cdx1 expression, some of which were computationally predicted to target CDX2 mRNA We have hypothesized in the present study that Cdx1 fine-tunes the expression of the CDX2 gene through specific miRNAs. Therefore we computationally predicted miRNAs that target CDX2 mRNA using the algorithms PicTar (http://pictar.mdc-berlin.de/) and TargetScan (http://www.targetscan.org/), and identified 16 miRNAs that could putatively bind to the 3 UTR of CDX2 BiochemJ.org/bj/447/bj4470449add.htm). Interestingly, only a marginal number of targets were predicted in the CDX1 mRNA 3 UTR, although both Cdx1 and Cdx2 are paralogues that originated from the chicken CdxA gene. This suggested that CDX1 and CDX2 are regulated in a distinct manner, at least in terms of targeting by miRNAs. To investigate the possibility that miRNAs have important roles in Cdx2 suppression, we first performed miRNA microarray analysis to detect the miRNAs that are induced by Cdx1. SW480 cells transduced with a CDX1 retrovirus vector, which reduced the Cdx2 protein levels ( Figure 1A) , were used for the microarray analysis. Nine out of 16 miRNAs predicted to target Cdx2 were found to be up-regulated, whereas only two were found to be down-regulated when compared with mocktransduced SW480 cells (Table 1 and Figure 3 ). The remainder of the predicted miRNAs was not detectable in either the empty or CDX1-integrated samples. On the basis of these miRNA microarray results, we selected ten miRNAs (indicated by circles and rectangles in Figure 3) for further analysis by quantitative RT-PCR. Using the same RNA samples, we found a good correlation between the quantitative RT-PCR and microarray results (Table 1) . miR-9, miR-15a/miR-15b/miR-16, miR-22, miR-107 and miR-181a/miR-181b were then selected as the first panel of candidate miRNAs that are responsible for Cdx2 suppression via Cdx1 in tumour cells.
To further examine the activity of our candidate miRNA series, we constructed a reporter vector containing the 3 UTR of CDX2 mRNA downstream of the Renilla luciferase gene. In the same plasmid, the firefly luciferase gene was included as an internal control (Supplementary Figure S1) . The result of the reporter assays indicated that the induction of Cdx1 in SW480 cells caused a 38.9 % (with an S.D. of 1.8) reduction in luciferase activity, indicating that Cdx1 suppresses CDX2 mRNA expression through the 3 UTR of these transcripts. To induce the exogenous expression of each of our candidate miRNAs, we prepared retrovirus vectors that express the corresponding pre-miRNA from the U6 promoter via RNA polymerase III. We next constructed reporter vectors containing either a wild-type or mutated 3 UTR of CDX2 mRNA cloned from the HCT116 cell line. We mutated the putative miRNA-binding sites so that the seed sequences of the known human miRNAs targeting this region would not match (Figure 2) . The results of co-transfection experiments using miRNAs and these reporter vectors into SW480 cells indicated that miR-9, miR-16 and miR-22 could suppress luciferase activity ( Figure 4A ), whereas miR-107 and miR-181b failed to do so (results not shown). Interestingly, it has been previously reported that, in gastric cancer cells, miR-9 down-regulates Cdx2 expression [17] . Importantly, miR-16 and miR-22 did not suppress reporter activity for the mutant vectors, indicating that these miRNAs suppress CDX2 by directly binding to the 3 UTR of its transcripts. Interestingly, however, the luciferase activity levels of the reporter vector harbouring mutant miR-9-binding sites was not fully released from suppression by exogenous miR-9. This suppression was completely suppressed only when both the miR-9-and miR-16-binding sites were mutated ( Figure 4A ). Since exogenous miR-9 expression did not significantly alter the endogenous miR-16 levels (Supplementary Figure S4 at http://www.BiochemJ.org/ bj/447/bj4470449add.htm), we speculate from this finding that miR-9 might also affect miR-16-binding sites indirectly by regulating RNA-binding proteins that are associated with CDX2 mRNA.
Importantly in this regard, the transfection of any of these three miRNAs to SW480 cells resulted in the down-regulation of endogenous CDX2 mRNA ( Figure 4B ). Overall, these results indicate that miR-9, miR-16 and miR-22 are induced by exogenous Cdx1 expression and target CDX2 mRNA to reduce its levels through the direct binding of its 3 UTR, as well as through some additional mechanisms.
miR-9, miR-16 and miR-22 play a critical role in suppressing Cdx2 through exogenous Cdx1 expression
To finally understand the significance of miR-9, miR-16 and miR-22 during Cdx2 suppression by exogenous Cdx1, we performed reporter assays in SW480 cells transduced with CDX1 retrovirus vector or with an empty vector. Reporters having only mutations in the binding sites for miR-9, miR-16 or miR-22 failed to recover from the suppression by Cdx1. We found, however, that the mutations in both miR-9-and miR-16-binding sites led to an almost full recovery of luciferase activity from suppression by Cdx1 ( Figure 5 ). Our observations that simultaneous mutations of both the miR-9-and miR-16-binding sites in the 3 UTR of CDX2 mRNA blocks Cdx2 suppression indicate the critical roles of these miRNAs in this regulatory event of this colorectal tumour cell line.
DISCUSSION
In the present study, we hypothesized that, in colorectal cells, Cdx1 expression suppresses Cdx2 expression through the activity of some miRNAs. To test this possibility, we first identified several miRNAs which are induced by exogenous Cdx1 expression using high-throughput screening ( Figure 3 and Table 1 ). Among the induced miRNAs we identified, we found that miR-9, miR-16 and miR-22 can efficiently target the 3 UTR of CDX2 mRNA ( Figure 4A ). The miRNA-binding sites were pin-pointed within the 3 UTR; two were identified for each of the three miRNAs. Since simultaneous mutation of the two sites for miR-9 is not sufficient for full recovery from the suppression by exogenous miR-9 introduction, we speculated that there may be some other miR-9-binding sites and/or some other indirect suppression mechanisms that involve these sites ( Figure 4A ). We further confirmed that the exogenous expression of each of these miRNAs reduces the levels of the endogenous CDX2 mRNA ( Figure 4B ).
There are two human miR-16 gene loci (miR-16-1 and miR-16-2) which simultaneously produce miR-15a and miR-15b respectively, both of which are elevated by the exogenous introduction of Cdx1 (Table 1) , i.e. both loci are Cdx1-responsive. Since miR-16, miR-15a and miR-15b share the same seed sequence, we anticipate that miR-15a and miR-15b may also contribute to the Cdx1 suppression of Cdx2. Interestingly, it has been reported that Cdx2 is down-regulated by phosphorylation via CDK2 (cyclin-dependent kinase 2) leading to its degradation following polyubiquitination [2, 18] . However, since the results of the present study indicate that Cdx1 represses CDX2 mRNA and protein to similar extents, we think that Cdx2 suppression is mainly caused by a direct function of Cdx1-inducible miRNAs.
We then evaluated how mutations within the identified binding sites for miR-9, miR-16 or miR-22 respectively, would effect reporters carrying the 3 UTR of CDX2 in Cdx1-introduced cells ( Figure 5 ). Interestingly, mutations in any one of these miRNAbinding sites alone did not cause a release from the suppression by Cdx1. This result is consistent with the idea that multiple miRNAs that target the same mRNA would often co-operate to achieve significant suppression. In this respect, the fact that the simultaneous mutations on both miR-9-and miR-16-binding sites almost fully cancelled out Cdx2 suppression is a notable finding. It suggests that there are very critical roles for these two miRNAs in Cdx2 suppression, at least in this colorectal cell line. Importantly, the miR-22 gene is also Cdx1-responsive (Table 1 and Figure 3) , and miR-22 clearly targets CDX2 mRNA (Figure 4 ). Therefore we believe miR-22 would also play crucial roles in Cdx2 suppression in many intestinal cells.
In summary, we have successfully identified a robust regulatory mechanism and some key factors involved in Cdx2 suppression by Cdx1, which would at least partly explain the mutually exclusive expression patterns for these proteins reported in the intestinal epithelia of mice. This regulatory network formed by miRNAs themselves reveals the importance of homoeostasis and the control of the transcriptional regulatory system through the limiting of transcription factors that share DNA recognition sequences. It has been proposed that miRNA fine-tunes regulatory networks [19] and we have previously reported that miRNAs can also function as molecular switches forming double-negative feedback loops [20, 21] . Therefore the results of the present study reveal a novel dimension of miRNA function which regulates expression levels among family members of the coding genes. By this regulatory mechanism, the levels of either Cdx1 or Cdx2 would be carefully regulated to establish and maintain stable gradients of their expression along the anterior-posterior axis of the gut [1] . This further suggests that Cdx1 and Cdx2 have distinct functions in the intestinal epithelium. To resolve the apparent functional differences between Cdx1 and Cdx2, further analyses both in vitro and in vivo (human and mouse intestinal epithelium), e.g. in situ hybridization of miRNA that we have developed [21, 22] and immunohistochemical staining of Cdxs are needed. Takanobu 
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